| [1] |
Goodarzi MO，Dumesic DA，Chazenbalk G，et al.Polycystic ovary syndrome：etiology, pathogenesis and diagnosis[J]．Nat Rev Endocrinol，2011，7 (4)：219–231.
|
| [2] |
DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment[J]. Fertil Steril，2005，83(5)：1454–1560.
|
| [3] |
Pasquali R，Stener-Victorin E, Yildiz BO，et al.PCOS forum: research in polycystic ovary syndrome today and tomorrow[J]．Clin Endocrinol (Oxf)，2011，74(4): 424–433.
|
| [4] |
Legro RS, Arslanian SA, Ehrmann DA，et al.Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013，98(12)：4565–4592.
|
| [5] |
Hughes C, Elgasim M, Layfield R，et al.Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review[J]. Hum Reprod，2006，21(11): 2766–2775.
|
| [6] |
Swinbanks D．Government backs proteome proposal[J]. Nature，1995, 378(6558)：653.
|
| [7] |
Weiss W, Görg A. High-resolution two-dimensional electrophoresis[J]．Methods Mol Biol, 2009，564：13–32.
|
| [8] |
Görg A，Weiss W，Dunn MJ.Current two-dimensional electrophoresis technology for proteomics[J]. Proteomics，2004, 4(12): 3665–3685.
|
| [9] |
Gloerich J，Wexers RA, Smeitink JA，et al. Proteomic of approaches to study genetic and metabolic disorders[J]. J Proteome Res，2007，6(2)：506–512.
|
| [10] |
Suss C，Solimena M．Proteomic profiling of beta-cells using a classical approach- two-dimensional gel electrophoresis[J]．Exp Clin Endocrinol Diabetes，2008，116：13–20.
|
| [11] |
Wong SC, Chan CM, Ma BB，et al. Advanced proteomic technologies for cancer biomarker discovery[J]. Expert Rev Proteomics, 2009，6(2)：123–134.
|
| [12] |
Wang H, Hanash S. Multi dimensional liquid phase based separations in proteomics[J]. J Chromatogr B Analyt Technol Biomed Life Sci，2003，787(1)：11–18.
|
| [13] |
Choi DH，Lee WS, Won M，et al. The apolipoprotein A-Ⅰ level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis[J]. J Proteome Res，2010, 9(9)：4329–4336.
|
| [14] |
Chapman K．The ProteinChip Biomarker System from Ciphergen Biosystems：a novel proteomics platform for rapid biomarker discovery and validation[J]. Biochem Soc Trans，2002, 30(2)：82–87.
|
| [15] |
Ma X, Fan L, Meng Y，et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome[J]. Mol Hum Reprod，2007, 13(8): 527–535.
|
| [16] |
Kim YS, Gu BH, Choi BC，et al. Apolipoprotein A-Ⅳ as a novel gene associated with polycystic ovary syndrome[J]．Int J Mol Med，2013，31(3)：707–716.
|
| [17] |
Dai G, Lu G. Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation[J]. Reprod Fertil Dev，2012，24(7): 893–904.
|
| [18] |
Corton M, Botella-Carretero JI, Lopez JA，et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry[J]. Hum Reprod，2008，23(3): 651–661.
|
| [19] |
Insenser M, Martinez-Garcia MA, Montes R，et al. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation[J]. J Clin Endocrinol Metab，2010，95(8): 3863–3870.
|
| [20] |
Montes-Nieto R, Insenser M，Martínez-García MÁ，et al.A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes[J]. J Clin Endocrinol Metab，2013，98(3): E576–E585.
|
| [21] |
Zhao S, Qiao J, Li M, et al.Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry[J]. Fertil Steril，2007，88(1): 145–151.
|
| [22] |
Liu JJ，Ma X，Cai LB, et al. Downregulation of both gene expression and activity of HSP 27 improved maturation of mouse oocyte in vitro[J]. Reprod Biol Endocrinol，2010, 8：47.
|
| [23] |
Insenser M, Martínez-García MA，Montes R，et al. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation[J]. J Clin Endocrinol Metab, 2010, 95(8)：3863–3870.
|
| [24] |
Atiomo WU，Khalid S，Ziauddin A，et al.Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome[J]．Expert Rev Proteomics，2009，6(5)：469–499.
|
| [25] |
秦芬，丘彦，杨曦，等．多囊卵巢综合征差异蛋白质组分析[J]．重庆医科大学学报，2010，35(1)：22–24.
|
| [26] |
张丽静，丘彦．多囊卵巢综合征胰岛素抵抗差异蛋白的分析[J]．重庆医科大学学报，2011，36(2)：145–147.
|
| [27] |
Matharoo-Ball B, Hughes C，Lancashire L，et al.Characterization of biomarkers in polycystic ovary syndrome(PCOS) using multiple distinct proteomic platforms[J]．J Proteome Res，2007，6(8): 3321–3328.
|
| [28] |
Galazis N, Afxentiou T, Xenophontos M，et al.Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome[J]. Eur J Endocrinol，2013，168(2): R33–R43.
|
| [29] |
Galazis N, Olaleye O, Haoula Z，et al. Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration[J]. Fertil Steril，98(6)：1590–1601.
|
| [30] |
Galazis N, Pang YL, Galazi M，et al. Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration[J]. Gynecol Endocrinol, 2013, 29(7): 638–644.
|
| [31] |
Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects[J]. Mol Cell Proteomics，2002，1(11): 845–867.
|